David Wrench

3.8k total citations
28 papers, 538 citations indexed

About

David Wrench is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, David Wrench has authored 28 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 8 papers in Oncology. Recurrent topics in David Wrench's work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (6 papers). David Wrench is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (6 papers). David Wrench collaborates with scholars based in United Kingdom, Canada and United States. David Wrench's co-authors include Paul Fields, Daniel Smith, N. George Mikhaeel, Henrik Møller, Joel Dunn, Sally F. Barrington, Michael Phillips, John G. Gribben, Jude Fitzgibbon and T. Andrew Lister and has published in prestigious journals such as Blood, PLoS ONE and American Sociological Review.

In The Last Decade

David Wrench

24 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wrench United Kingdom 10 379 162 159 125 110 28 538
Violaine Safar France 10 281 0.7× 184 1.1× 127 0.8× 171 1.4× 94 0.9× 24 529
Mohamed Darif United States 12 481 1.3× 291 1.8× 322 2.0× 129 1.0× 153 1.4× 27 791
Christian W. Scholz Germany 12 295 0.8× 253 1.6× 72 0.5× 140 1.1× 156 1.4× 38 544
Maria Giuseppina Cabras Italy 13 605 1.6× 261 1.6× 149 0.9× 184 1.5× 123 1.1× 30 768
Lisa Downs United States 10 421 1.1× 158 1.0× 216 1.4× 58 0.5× 136 1.2× 23 605
Laura Clifton‐Hadley United Kingdom 15 325 0.9× 191 1.2× 114 0.7× 125 1.0× 109 1.0× 50 574
Anna Vanazzi Italy 12 252 0.7× 162 1.0× 99 0.6× 80 0.6× 62 0.6× 42 352
Annette Hänel Germany 8 462 1.2× 307 1.9× 110 0.7× 229 1.8× 89 0.8× 13 639
Manfred Welslau Germany 7 335 0.9× 306 1.9× 49 0.3× 228 1.8× 77 0.7× 28 501
Judith Huerta‐Guzmán Mexico 17 400 1.1× 400 2.5× 61 0.4× 97 0.8× 96 0.9× 42 666

Countries citing papers authored by David Wrench

Since Specialization
Citations

This map shows the geographic impact of David Wrench's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wrench with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wrench more than expected).

Fields of papers citing papers by David Wrench

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wrench. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wrench. The network helps show where David Wrench may publish in the future.

Co-authorship network of co-authors of David Wrench

This figure shows the co-authorship network connecting the top 25 collaborators of David Wrench. A scholar is included among the top collaborators of David Wrench based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wrench. David Wrench is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amin, Mohammad, Oliver Brunckhorst, Charles Scott, et al.. (2020). ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma. Clinical & Translational Oncology. 23(6). 1067–1077. 18 indexed citations
2.
Moonim, Mufaddal, et al.. (2020). Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report. American Journal of Case Reports. 21. e921840–e921840. 1 indexed citations
3.
Mukhtyar, Chetan, David Jayne, Aftab Ala, et al.. (2019). Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review. Autoimmunity Reviews. 18(5). 535–541. 23 indexed citations
4.
Michalarea, Vasiliki, Ryan Low, Amy A. Kirkwood, et al.. (2019). EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. Hematological Oncology. 37(S2). 425–426. 1 indexed citations
5.
Manwani, Richa, David Wrench, Ashutosh Wechalekar, & Helen J. Lachmann. (2018). Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma. British Journal of Haematology. 182(5). 619–619. 2 indexed citations
6.
Jayne, David, Chetan Mukhtyar, Aftab Ala, et al.. (2018). Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases. Lara D. Veeken. 58(5). 889–896. 35 indexed citations
7.
8.
Marcus, Robert, Stella Bowcock, Stephen Devereux, et al.. (2017). Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study. Leukemia & lymphoma. 58(9). 2051–2056. 8 indexed citations
9.
Fields, Paul & David Wrench. (2017). Hodgkin lymphoma. Medicine. 45(5). 305–310. 3 indexed citations
10.
Mikhaeel, N. George, Daniel Smith, Joel Dunn, et al.. (2016). Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL. European Journal of Nuclear Medicine and Molecular Imaging. 43(7). 1209–1219. 209 indexed citations
11.
Carlotti, Emanuela, David Wrench, Guglielmo Rosignoli, et al.. (2015). High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution. PLoS ONE. 10(9). e0134833–e0134833. 26 indexed citations
12.
Wrench, David, Hasan Rizvi, Andrew Wilson, et al.. (2013). Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma. Blood. 122(21). 4260–4260. 2 indexed citations
13.
Wrench, David, Christine F. Skibola, Lucía Conde, et al.. (2011). SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma. Blood. 117(11). 3147–3150. 15 indexed citations
14.
Wrench, David, Silvia Montoto, & Jude Fitzgibbon. (2010). Molecular signatures in the diagnosis and management of follicular lymphoma. Current Opinion in Hematology. 17(4). 333–340. 2 indexed citations
15.
16.
O’Shea, Derville, Ciarán Ó’Riain, Manu Gupta, et al.. (2009). Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood. 113(10). 2298–2301. 49 indexed citations
17.
Wrench, David & John G. Gribben. (2008). Stem Cell Transplantation for Non-Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America. 22(5). 1051–1079. 16 indexed citations
18.
Duarte, Rafael F., Julio Delgado, Bronwen E. Shaw, et al.. (2005). Histologic Features of the Liver Biopsy Predict the Clinical Outcome for Patients with Graft-versus-Host Disease of the Liver. Biology of Blood and Marrow Transplantation. 11(10). 805–813. 19 indexed citations
19.
Duarte, Rafael F., et al.. (2004). Graft-versus-host disease of the liver: 109 cases from a single-centre. UCL Discovery (University College London). 1 indexed citations
20.
Wrench, David, Irwin A. Berg, & Bernard M. Bass. (1962). Conformity and Deviation.. American Sociological Review. 27(3). 435–435. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Violaine Safar Breakdown of academic impact, for papers by Mohamed Darif Breakdown of academic impact, for papers by Christian W. Scholz Breakdown of academic impact, for papers by Maria Giuseppina Cabras Breakdown of academic impact, for papers by Lisa Downs Breakdown of academic impact, for papers by Laura Clifton‐Hadley Breakdown of academic impact, for papers by Anna Vanazzi Breakdown of academic impact, for papers by Annette Hänel Breakdown of academic impact, for papers by Manfred Welslau Breakdown of academic impact, for papers by Judith Huerta‐Guzmán
Rankless by CCL
2026